1. Volume 57, Issue 5, Pages 891-896 (May 2010)
Complete Continence after Botulinum Neurotoxin Type A Injections for Refractory Idiopathic Detrusor Overactivity Incontinence: Patient-Reported Outcome at 4 Weeks 
Shahid Khan, Jalesh Panicker, Alexander Roosen, Gwen Gonzales, Sohier Elneil, Prokar Dasgupta, Clare J. Fowler, Thomas M. Kessler 
European Urology 
Volume 57, Issue 5, Pages (May 2010)
DOI: /j.eururo
Copyright © 2009 European Association of Urology Terms and Conditions

2. Fig. 1
Patient-reported incontinence before and 4 wk after intradetrusor injections of botulinum neurotoxin type A (BoNT/A) using the subscales of the validated Urogenital Distress Inventory (UDI 6) questionnaire in 74 patients.
European Urology  , DOI: ( /j.eururo )
Copyright © 2009 European Association of Urology Terms and Conditions

3. Fig. 2
Decline in patient-reported median Urogenital Distress Inventory subscales of frequency, urgency incontinence, and stress incontinence before versus 4 wk after botulinum neurotoxin type A (BoNT/A) injections.
European Urology  , DOI: ( /j.eururo )
Copyright © 2009 European Association of Urology Terms and Conditions